All lobbying filings
THE VOGEL GROUP
Lobbying for NEPHRON PHARMACEUTICALS CORPORATION · Developer and manufacturer of sterile inhalation and 503B outsourcing medication.
Filing
1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
South Carolina
Lobbyists on this filing
1
-
ALEXANDER NICHOLAS VOGEL SRPreviously held: Former Chief Counsel, Senate Majority Leader Bill Frist
Government bodies contacted
1
Lobbying activity
1
Issues relating to facility operations